Journal: Cell Death & Disease
Article Title: Involvement of p38 MAPK and MAPKAPK2 in promoting cell death and the inflammatory response to ischemic stress associated with necrotic glioblastoma
doi: 10.1038/s41419-025-07335-3
Figure Lengend Snippet: A Kaplan–Meier survival curves comparing mice intracranially injected with LN229 vector , LN229 KRAS(G12D) , or LN229 PIK3CA(H1047R) cells. B H&E-stained tumor sections derived from LN229 vector , LN229 KRAS(G12D) or LN229 PIK3CA(H1047R) terminal tumors. C Quantification of the necrotic area presented as the percentage of total tumor area in H&E-stained tumor sections from LN229 vector , LN229 KRAS(G12D) or LN229 PIK3CA(H1047R) tumors. Ordinary one-way ANOVA test. D Immunofluorescent staining of mouse neutrophil marker, Ly6G, hypoxia marker, pimonidazole, and DAPI on paraffin-embedded sections of LN229 KRAS(G12D) - or LN229 PIK3CA(H1047R) -derived tumors upon reaching endpoints. E Chromogenic staining of p-MK2 on paraffin-embedded sections of LN229 KRAS(G12D) - or LN229 PIK3CA(H1047R) -derived endpoint tumors. In B , D , and E , N denotes tumor necrosis, and CT denotes cellular tumor. In D , the right images depict magnified views of the corresponding outlined areas from the left images. F Growth curve of LN229 KRAS(G12D) or LN229 PIK3CA(H1047R) cells cultured under regular conditions. (n = 3). G The size of tumors derived from LN229 KRAS(G12D) or LN229 PIK3CA(H1047R) cells transduced by an empty vector (EV) or p38 gRNA (KO-p38) was monitored using bioluminescence imaging. (n = 10 mice for each group, except n = 9 for EV of each tumor type at the last time point). Multiple unpaired t-test. H Kaplan-Meier survival curves comparing mice intracranially injected with p38α-depleted (KO-p38) LN229 KRAS(G12D) or LN229 PIK3CA(H1047R) cells. Log-rank test. I Quantification of the necrotic area presented as the percentage of total tumor area in H&E-stained tumor sections from LN229 KRAS(G12D) cells transduced by EV or KO-p38. Student’s t test.
Article Snippet: The antibodies used for western blotting and immunohistochemistry staining included: ATF4 (Cell Signaling Technology, 11815), p-EIF2a (S51) (Cell Signaling Technology, 3398), β-actin (Cell Signaling Technology, 3700), p-p38 (T180/Y182) (Cell Signaling Technology, 4511), p38 (Cell Signaling Technology, 8690), p-MK2 (T334) (Cell Signaling Technology, 3007), MK2 (Cell Signaling Technology, 12155), p-ERK (Cell Signaling Technology, 4370), p-AKT(S473) (Cell Signaling Technology, 4060), anti-rabbit HRP-conjugated secondary antibody (Cell Signaling Technology, 7074S), anti-mouse HRP-conjugated antibody (Cell Signaling Technology, 7076S).
Techniques: Injection, Plasmid Preparation, Staining, Derivative Assay, Marker, Cell Culture, Imaging